The U.S. FDA ban on compounded versions of Novo Nordisk's Wegovy has increased its prescriptions by 33%. Despite this, ...

While the regulator’s proposed revamp of fund categorisation rules tackle fund proliferation and portfolio overlap, outdated ...

New mutual fund entrant The Wealth Company has announced the filing of Scheme Information Documents (SIDs) for four new ...